The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1540
ISSUE 1540
February 12, 2018
Issue 1540
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Nonopioid Drugs for Pain
February 12, 2018 (Issue: 1540)
Nonopioid drugs can be used in the treatment of many
nociceptive and neuropathic pain conditions. Use of
opioids for pain will be reviewed in a future issue.
- DE Becker et al. Pain management: Part 1: Managing acute and postoperative dental pain. Anesth Prog 2010; 57:67.
- Intravenous acetaminophen (Ofirmev). Med Lett Drugs Ther 2011; 53:26.
- Acetaminophen safety - Deja vu. Med Lett Drugs Ther 2009; 51:53.
- PB Watkins et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006; 296:87.
- In brief: Does acetaminophen increase blood pressure? Med Lett Drugs Ther 2011; 53:29.
- Addendum: Warfarin-acetaminophen interaction. Med Lett Drugs Ther 2008; 50:45.
- S Karami et al. Analgesic use and risk of renal cell carcinoma: a case-control, cohort and meta-analytic assessment. Int J Cancer 2016; 139:584.
- JA Forbes et al. Evaluation of bromfenac, aspirin, and ibuprofen in postoperative oral surgery pain. Pharmacotherapy 1991; 11:64.
- M Nauta et al. Codeine-acetaminophen versus nonsteroidal anti-inflammatory drugs in the treatment of post-abdominal surgery pain: a systematic review of randomized trials. Am J Surg 2009; 198:256.
- Intravenous diclofenac (Dyloject). Med Lett Drugs Ther 2015; 57:171.
- PL McCormack. Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Drugs 2011; 71:2457.
- Low-dose diclofenac (Zorvolex) for pain. Med Lett Drugs Ther 2014; 56:19.
- In brief: Low-dose indomethacin (Tivorbex) for pain. Med Lett Drugs Ther 2014; 56:64.
- Low-dose meloxicam (Vivlodex) for osteoarthritis pain. Med Lett Drugs Ther 2016; 58:35.
- WT Enthoven et al. Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev 2016; 2:CD012087.
- GC Machado et al. Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis. Ann Rheum Dis 2017; 76:1269.
- A Qaseem et al. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2017; 166:514.
- FKL Chan et al. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial. Lancet 2017; 389:2375.
- Primary prevention of ulcers in patients taking aspirin or NSAIDs. Med Lett Drugs Ther 2010; 52:17.
- Naproxen/esomeprazole (Vimovo). Med Lett Drugs Ther 2010; 52:74.
- A fixed-dose combination of ibuprofen and famotidine (Duexis). Med Lett Drugs Ther 2011; 53:85.
- S Trelle et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011; 342:c7086.
- P McGettigan and D Henry. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 2011; 8:e1001098.
- KB Sondergaard et al. Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case-time-control study. Eur Heart J Cardiovasc Pharmacother 2017; 3:100.
- SE Nissen et al. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016; 375:2519.
- Celecoxib safety revisited. Med Lett Drugs Ther 2016; 58:159.
- TK Choueiri et al. Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies. Int J Cancer 2014; 134:384.
- AK Chang et al. Effect of a single dose of oral opioid and nonopioid analgesics on acute extremity pain in the emergency department: a randomized clinical trial. JAMA 2017; 318:1661.
- W Häuser et al. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs 2012; 26:297.
- R Aiyer et al. Treatment of neuropathic pain with venlafaxine: a systematic review. Pain Med 2017; 18:1999.
- LA VanderWeide et al. A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia. J Clin Pharm Ther 2015; 40:1.
- Duloxetine (Cymbalta) for diabetic neuropathic pain. Med Lett Drugs Ther 2005; 47:67.
- Duloxetine (Cymbalta) for fibromyalgia. Med Lett Drugs Ther 2008; 50:57.
- Duloxetine (Cymbalta) for chronic musculoskeletal pain. Med Lett Drugs Ther 2011; 53:33.
- Milnacipran (Savella) for fibromyalgia. Med Lett Drugs Ther 2009; 51:45.
- NB Finnerup et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14:162.
- Gabapentin (Neurontin) for chronic pain. Med Lett Drugs Ther 2004; 46:29.
- Pregabalin (Lyrica) for neuropathic pain and epilepsy. Med Lett Drugs Ther 2005; 47:75.
- W Häuser et al. Treatment of fibromyalgia syndrome with gabapentin and pregabalin—a meta-analysis of randomized controlled trials. Pain 2009; 145:69.
- S Mathieson et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med 2017; 376:1111.
- KE Evoy et al. Abuse and misuse of pregabalin and gabapentin. Drugs 2017; 77:403.
- GC Quintero. Review about gabapentin misuse, interactions, contraindications and side effects. J Exp Pharmacol 2017; 9:13.
- M Zhou et al. Oxcarbazepine for neuropathic pain. Cochrane Database Syst Rev 2017; 12:CD007963.
- I Gilron et al. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009; 374:1252.
- S Tesfaye et al. Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"—a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain. Pain 2013; 154:2616.
- I Gilron et al. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005; 352:1324.
- T Gomes et al. Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study. PLoS Med 2017; 14:e1002396.
- M Sanford. Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics. CNS Drugs 2013; 27:989.
- GC McDowell 2nd and JE Pope. Intrathecal ziconotide: dosing and administration strategies in patients with refractory chronic pain. Neuromodulation 2016; 19:522.
- Ziconotide (Prialt) for chronic pain. Med Lett Drugs Ther 2005; 47:103.
- CJ Derry et al. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Rev 2014; 12:CD009281.
- J Park and HJ Park. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel) 2017; 9:E260.
- PF Whiting et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313:2456.
- Cannabis and cannabinoids. Med Lett Drugs Ther 2016; 58:97.
- SM Nugent et al. The effects of cannabis among adults with chronic pain and an overview of general harms: a systematic review. Ann Intern Med 2017; 167:319.
- PS Davies and BS Galer. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 2004; 64:937.
- Capsaicin patch (Qutenza) for postherpetic neuralgia. Med Lett Drugs Ther 2011; 53:42.
- FDA. Drug Safety Communication: rare cases of serious burns with the use of over-the-counter topical muscle and joint pain relievers. Available at www.fda.gov. Accessed February 1, 2018.
- J Schneiderhan et al. Primary care of patients with chronic pain. JAMA 2017; 317:2367.
- RB Saper et al. Yoga, physical therapy, or education for chronic low back pain: a randomized noninferiority trial. Ann Intern Med 2017; 167:85.
- LJ Geneen et al. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews. Cochrane Database Syst Rev 2017; 4:CD011279.
- D Green et al. Effects of diflunisal on platelet function and fecal blood loss. Pharmacotherapy 1983; 3(2 pt 2):65S.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this issue? Gain access below.
Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1540
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.